Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy? In response to: Hypocomplementemia at Diagnosis of Pauciimmune Glomerulonephritis Is Associated… Click to show full abstract
Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy? In response to: Hypocomplementemia at Diagnosis of Pauciimmune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/ j.ekir.2021.05.043)
               
Click one of the above tabs to view related content.